Red Rock Resorts earnings beat by $0.54, revenue topped estimates
In a recent transaction, Tommy G. Thompson, a director at Healthpeak Properties, Inc. (NYSE:DOC), acquired 5,777 shares of the company’s common stock. The healthcare REIT, known for its impressive 41-year streak of dividend payments and current 7% yield, continues to attract insider interest. This purchase, completed on May 28, 2025, was made at a price of $17.27 per share, amounting to a total investment of $99,768. According to InvestingPro analysis, the stock appears undervalued at current levels, with analysts setting price targets ranging from $21 to $29. Following this transaction, Thompson’s direct ownership in the company stands at 144,290 shares. For deeper insights into Healthpeak Properties’ valuation and 8 additional key ProTips, check out the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Healthpeak Properties, Inc. reported its first-quarter 2025 earnings, surpassing analysts’ expectations with earnings per share of $0.06, compared to the forecasted $0.0519. The company’s revenue also exceeded predictions, reaching $702.89 million against the expected $683.39 million. Despite these positive financial results, Healthpeak maintained its full-year guidance for adjusted funds from operations at $1.81 to $1.87 per share. The company highlighted strategic initiatives, including significant property management internalization and asset sales, as part of its ongoing efforts to optimize its portfolio. Healthpeak’s diversified portfolio, with a significant presence in life sciences, outpatient medical, and senior housing, positions it to navigate industry challenges effectively. The company also emphasized its available liquidity of $2.8 billion, which supports future investments. Healthpeak’s management reiterated their focus on flexible capital allocation, with plans to invest $500 million in high-quality assets.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.